Acute Lung Injury Market Analysis, Scope, and Growth by 2028
Acute Lung Injury Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 539.61 Million |
Market Size by 2028 | US$ 741.98 Million |
Global CAGR (2021 - 2028) | 4.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Therapy
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
By Therapy
- Mechanical Ventilation
- Fluid Management
- Pharmacotherapy
- Adjunctive Procedures
By End User
- Hospitals
- Ambulatory Surgery Centers
- Others
By
Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- GlaxoSmithKline plc.
- Stemedica Cell Technologies, Inc
- Histocell
- APEPTICO Forschung und Entwicklung GmbH
- Windtree Therapeutics, Inc.
- ReAlta Life Sciences, Inc.
- Apeiron Biologics AG
- Qx Therapeutics, Inc.
- Angion
- Asklepion Pharmaceuticals, LLC